Condition
Stem Cell Surveillance
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07142720Not ApplicableCompleted
Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity
NCT07341178Not ApplicableNot Yet RecruitingPrimary
Acute Effects on Stem Cell Surveillance
NCT07127705Not ApplicableRecruitingPrimary
Rapid Response of Stem Cells and Immune Cells for Efficacy
Showing all 3 trials